QP2-TZ 30mg
Dual incretin-receptor agonist studied in metabolic and glycemic research.
QP2-TZ is a 39-amino-acid synthetic peptide that activates two incretin receptors at once. Its backbone is modeled on a native incretin sequence, with Aib residues at positions 2 and 13, a C-terminal amide, and a C20 fatty diacid attached to lysine 20 for albumin binding. Molecular weight is about 4813.5 Da (CAS 2023788-19-2).
QP2-TZ is studied as the reference dual incretin-receptor agonist. Research questions include how simultaneous engagement of both receptors compares with single-receptor agonism, how biased signaling at each receptor affects cAMP production and receptor internalization, and how the dual profile alters lipid handling in adipose tissue models.
This 30 mg vial has a third-party certificate of analysis (batch COA #10449, 99.94% by RP-HPLC, issued by Bioviridian Inc.). Lyophilized and supplied for research use only.
Research areas: Dual incretin-receptor agonism, Biased receptor signaling, Adipose tissue lipid metabolism, Incretin pharmacology.
Technical data
- Formula
- C225H348N48O68
- Molecular weight
- 4813 g/mol
- CAS
- 2023788-19-2
- PubChem CID
- 166567236
Category: Metabolic. Price: $75.00 USD. 99.94% HPLC purity (third-party lab tested, batch COA #10449: https://orderqualitypeptides.com/coa/COA10449.pdf).
All products are sold strictly for in-vitro laboratory research. Not for human or veterinary use. Not drugs or supplements.